Short answer · Medically reviewed summary · Last updated: 2026-04-06
Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis that is primarily known by its eponym, though it has historically been categorized under several descriptive terms. Recognized Synonyms and Historical Nomenclature While Erdheim-Chester disease (ECD) is the current standard, you may encounter the following names in medical literature or older patient records: Lipid granulomatosis: An older, descriptive term reflecting the accumulation of lipid-laden histiocytes. Polyostotic sclerosing histiocytosis: A name highlighting the condition's hallmark tendency to cause hardening (sclerosis) in multiple bones. Erdheim-Chester syndrome: A common variation used interchangeably with the disease name. Classification and Official Terminology The name Erdheim-Chester disease honors Jakob Erdheim and William Chester, who first described the condition in 1930. Because it is a rare histiocytic disorder, its classification has evolved as our understanding of its genetic drivers—specifically the frequent BRAF V600E mutation—has grown.
Erdheim Chester Disease synonyms
Other names for Erdheim Chester Disease: synonyms, acronyms and related terms used by doctors and patients.
Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis that is primarily known by its eponym, though it has historically been categorized under several descriptive terms.
Recognized Synonyms and Historical Nomenclature
While Erdheim-Chester disease (ECD) is the current standard, you may encounter the following names in medical literature or older patient records:
- Lipid granulomatosis: An older, descriptive term reflecting the accumulation of lipid-laden histiocytes.
- Polyostotic sclerosing histiocytosis: A name highlighting the condition's hallmark tendency to cause hardening (sclerosis) in multiple bones.
- Erdheim-Chester syndrome: A common variation used interchangeably with the disease name.
Classification and Official Terminology
The name Erdheim-Chester disease honors Jakob Erdheim and William Chester, who first described the condition in 1930. Because it is a rare histiocytic disorder, its classification has evolved as our understanding of its genetic drivers—specifically the frequent BRAF V600E mutation—has grown. In major clinical databases, it is officially listed as:
- Orphanet: ORPHA:28045
- OMIM: #614675
- ICD-10/11: Often coded under "Other specified histiocytoses" (D76.3)
Why Multiple Names Exist
The existence of multiple names for Erdheim-Chester disease stems from the historical evolution of pathology. Early physicians named the condition based on the visual appearance of tissue samples under a microscope (histiocytosis) or the physical impact on the skeletal system (sclerosing). As medicine shifted toward identifying the molecular mechanisms—such as the MAPK pathway activation—the medical community standardized the name Erdheim-Chester disease to ensure consistency in research and clinical trials. Today, using the eponym is the preferred standard across all medical specialties, including oncology, rheumatology, and hematology, to avoid confusion with other, distinct forms of histiocytosis.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- Orphanet: Erdheim-Chester disease (ORPHA:28045)
- NIH Genetic and Rare Diseases Information Center (GARD): Erdheim-Chester disease
- OMIM (Online Mendelian Inheritance in Man): #614675
- Erdheim-Chester Disease Alliance: Understanding the Condition
